Nutlin-3a inhibits the binding site of MDM2-p53, promotes p53 function, and increases chemotherapy-induced apoptosis in cancer cells lacking functional p53 by activating E2F2, while RITA avoids MDM2-induced p53 repression by binding to p53 [119]. Here, MDM2 is linked to cancer.